Urologic manifestations of nonurologic disease urolithiasis

Brian Matlaga, Dean G. Assimos

Research output: Contribution to journalArticle

Abstract

Patients with nephrolithiasis may have coexistent diseases that play a causative role in stone formation. A stone event may be the initial manifestation of the disorder and the urologist may play a major diagnostic role. Regulation or correction of the disorder may eradicate or dramatically attenuate stone activity. In some patients, metabolic abnormalities persist, however, and the therapeutic strategies that were reviewed in this manuscript may need to be implemented. Stone disease may also be induced by drugs that are used to treat a number of disease processes. When this occurs, the drug will usually need to be discontinued and alternative therapy should be instituted.

Original languageEnglish (US)
Pages (from-to)91-99
Number of pages9
JournalUrologic Clinics of North America
Volume30
Issue number1
DOIs
StatePublished - Feb 2003
Externally publishedYes

Fingerprint

Urolithiasis
Nephrolithiasis
Complementary Therapies
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Urologic manifestations of nonurologic disease urolithiasis. / Matlaga, Brian; Assimos, Dean G.

In: Urologic Clinics of North America, Vol. 30, No. 1, 02.2003, p. 91-99.

Research output: Contribution to journalArticle

@article{71254cb9df8e4c7eb399b5065962875f,
title = "Urologic manifestations of nonurologic disease urolithiasis",
abstract = "Patients with nephrolithiasis may have coexistent diseases that play a causative role in stone formation. A stone event may be the initial manifestation of the disorder and the urologist may play a major diagnostic role. Regulation or correction of the disorder may eradicate or dramatically attenuate stone activity. In some patients, metabolic abnormalities persist, however, and the therapeutic strategies that were reviewed in this manuscript may need to be implemented. Stone disease may also be induced by drugs that are used to treat a number of disease processes. When this occurs, the drug will usually need to be discontinued and alternative therapy should be instituted.",
author = "Brian Matlaga and Assimos, {Dean G.}",
year = "2003",
month = "2",
doi = "10.1016/S0094-0143(02)00121-0",
language = "English (US)",
volume = "30",
pages = "91--99",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Urologic manifestations of nonurologic disease urolithiasis

AU - Matlaga, Brian

AU - Assimos, Dean G.

PY - 2003/2

Y1 - 2003/2

N2 - Patients with nephrolithiasis may have coexistent diseases that play a causative role in stone formation. A stone event may be the initial manifestation of the disorder and the urologist may play a major diagnostic role. Regulation or correction of the disorder may eradicate or dramatically attenuate stone activity. In some patients, metabolic abnormalities persist, however, and the therapeutic strategies that were reviewed in this manuscript may need to be implemented. Stone disease may also be induced by drugs that are used to treat a number of disease processes. When this occurs, the drug will usually need to be discontinued and alternative therapy should be instituted.

AB - Patients with nephrolithiasis may have coexistent diseases that play a causative role in stone formation. A stone event may be the initial manifestation of the disorder and the urologist may play a major diagnostic role. Regulation or correction of the disorder may eradicate or dramatically attenuate stone activity. In some patients, metabolic abnormalities persist, however, and the therapeutic strategies that were reviewed in this manuscript may need to be implemented. Stone disease may also be induced by drugs that are used to treat a number of disease processes. When this occurs, the drug will usually need to be discontinued and alternative therapy should be instituted.

UR - http://www.scopus.com/inward/record.url?scp=0037310129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037310129&partnerID=8YFLogxK

U2 - 10.1016/S0094-0143(02)00121-0

DO - 10.1016/S0094-0143(02)00121-0

M3 - Article

VL - 30

SP - 91

EP - 99

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 1

ER -